US3924641A - Bi-phasic current stimulation system - Google Patents

Bi-phasic current stimulation system Download PDF

Info

Publication number
US3924641A
US3924641A US49874074A US3924641A US 3924641 A US3924641 A US 3924641A US 49874074 A US49874074 A US 49874074A US 3924641 A US3924641 A US 3924641A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
switches
bi
paths
switch
voltage terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Gerhard T Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventritex Inc
Original Assignee
AXOTRONICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36025External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain

Abstract

A circuit for producing current-controlled bi-phasic pulses to stimulate living tissue includes two conducting paths connected in parallel between high and low voltage terminals, with each of the conducting paths having first and second switches connected in series therein. The intersections of the respective first and second switches in each of the paths define output terminals across which bi-phasic pulses are produced. These output terminals include electrode members for electrically attaching them to living tissues. Interconnecting circuits connect the first switch of each of the conducting paths with the second switch of the other conducting path to respectively open and close the second switches in response to the first switches of opposite paths being opened and closed. A digital programmer alternately drives one of the first switches open and the other closed. Current controlling valves are connected in the paths between the low voltage terminal and the output terminals to selectively control current flow through the electrodes.

Description

United States Patent 1191 Weiss Dec. 9, 1975 Bl-PHASIC CURRENT STIMULATION Primary ExaminerRichard A. Gaudet SYSTEM Assistant ExaminerLee S. Cohen [75] Inventor; Gerhard Weiss, Northford Conn. Attorney, Agent, or Firm-Walter Spruegel [73] Assignee: Axotronics lnc., Hamden, Conn.

[57] ABSTRACT [22] Filed: Aug. 19, 1974 A circuit for producing current-controlled bi-phasic [21] PP No: 498,740 pulses to stimulate living tissue includes two conducting paths connected in parallel between high and low 52 US. Cl 128/419 PG; 128/421 W terminals with each of the csnducting PathS 51 1m. (:1. A61N l/36 havmg first and seem! switches in Series 5 Field f Search 128/42O, 421, 422 423, therein. The intersections of the respective first and 128/419 13, 419 C 419 E 419 G, 419 PG, second switches in each of the paths define output ter- 9 R minals across which bi-phasic pulses are produced. These output terminals include electrode members for 5 References Cited electrically attaching therlrli tto living tissutes. lrgerfcolrlinectin circuits connectt e irst switch 0 eac 0 t e UNITED STATES PATENTS condu ting paths with the second switch of the other LaVCZZT) conducting to respectively open and close the 2 a 419 P6 second switches in response to the first switches of op- 3:727:616 41973 1.5112122: izizi i i: posite paths being operfed and closed A digital 3,835,865 9/1974 Bowers 128/419 PG gramme alternately dm'es one of the first swltches Canada 128/419 R open and the other closed. Current controlling valves are connected in the paths between the low voltage terminal and the output terminals to selectively control current flow through the electrodes.

7 Claims, 2 Drawing Figures US. Patent Dec. 9, 1975 & mama VQZMGE /-4 BI-PHASIC CURRENT STIMULATION SYSTEM BACKGROUND OF THE INVENTION This invention relates broadly to the art of electronic stimulators and more particularly to devices for generating current controlled, bi-phasic pulses to stimulate areas of the brain, nerves, or other organs.

In behavioral research, stimulation of certain areas of the brain is often used to find ways to suppress intractable pain, aggressive behavior, or toexplore brain structures and their influence on the behavior of animals or humans. Brain stimulation is also applied in efforts to fight other disorders associated with the brain.

In addition to brain research, electrical stimulation is also widely used to restore proper functioning of various organs such as hearts, lungs, or bladders in cases where the control of these organs is disturbed because of disease, injury, or other causes.

The effects elicited by electrical stimulations are, to a large extent, determined by the amounts of current flow rather than by the magnitudes of applied voltages. Since the impedance between points of stimulation varies widely and may even change during stimulation, the current will also change even if the voltage is maintained at a constant level. This makes it difficult to control the amount of current flow. Thus, it is an object of this invention to provide an electrical stimulation circuit which provides an adjustable, controllable, stimulating current.

Further, if pulses of one polarity only are used for stimulation, electro/chemical effects tend to create unfavorable interactions between electrodes and tissues. Many researchers, therefore, prefer stimulation pulses in both polarities, such as with a negative pulse, followed immediately by a positive pulse, preferably each being of equal magnitude and duration. Thus, it is an object of this invention to provide an electrical circuit for providing such pulses.

Another object of this invention is to provide a circuit for generating bi-phasic, current-controlled pulses with current amplitudes of both negative and positive portions thereof being proportional to an applied control voltage.

Still another object of this invention is to provide a current controlled, bi-phasic or mono-phasic pulse generator whose output impedance is high enough to allow the use of its stimulation electrodes for measuring the response to stimulation, e.g. brain stimulation, EEG recordings and the like.

Still another object of this invention is to provide a circuit for generating bi-phasic or mono-phasic current controlled pulses, the characteristics of which are controlled by a programmer.

SUMMARY OF THE INVENTION first switch of the first path is interconnected to the second switch of the second path, and vice versa, to assure that the first and second switches of opposite paths are opened and closed together. A driving device alternately drives the first switch of the first path on or closed," and the first switch of the second path off,

2 or open, and vice versa. The driving mechanism measures the time period that the switches are in open and closed positions, Electronic valves are located in each of the first and second paths between the first voltage terminal and the output terminals to selectively control current flow to the electrodes.

BRIEF DESCRIPTION OF THE DRAWINGS The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of a preferred embodiment of the invention, as illustrated in the accompanying drawings in which reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention in a clear manner.

FIG. 1 is a schematic diagram of a current controlled, bi-phasis pulse generator employing principles of this invention; and

FIG. 2 is a diagrammatic representation of an output pulse of the bi-phasic pulse generator of FIG. 1.

DESCRIPTION OF THE PREFERRED EMBODIMENT The preferred embodiment of the pulse generator of this invention, illustrated in FIG. 1, comprises two first transistor switches 10 and 12, two second transistor switches 14 'and 16, a pair of current control valve devices 18 and 20, a digital programmer 22 and a control voltage generator 24. The pulse generator is energized by a +20 volts, positive voltage terminal 26 and a -20 volts, negative voltage terminal 28 and forms two parallel connected, main conducting paths 30 and 32 between these voltage terminals. In practice, a single 40 volt source could be used.

The first transistor switches 10 and 12 comprise PNP transistors Q1 and Q2 and 22K control resistors 34 and 36. The second transistor switches 14 and 16 comprise NPN transistors Q3 and Q4 and K control resistors 38 and 40, In this regard, the interconnection between the positive voltage terminal 26 and the base of the transistor Q1 via the resistor 34 holds transistor O1 in an off state when transistor Q4 is off and no current can flow through resistor 40. When transistor O4 is on, a current path is established from the positive voltage terminal 26 through both the Q1 base-to-emitter junction, and the resistor 34, the resistor 40, and the transistor O4 to the negative voltage terminal 28, thereby placing transistor O1 in an on state. There is a similar interaction between the resistors 36 and 38 and the transistors Q2 and Q3.

The first and second current control valve devices 18 and 20 respectively comprise NPN transistors Q5 and Q6 and series resistors 42 and 44.

In the preferred embodiment, the switching transistors Q1, Q2, Q3, and Q4 are chosen to operate, for practical purposes, in an on-off fashion while the current control transistors Q5 and Q6 are chosen to operate in a gradual manner for regulating current flow.

Electrodes 46 and 48, which are adapted to be electricallyattached to living tissue, are respectively electrically connected to the main conducting paths 30 and 32 between the transistor switch 10- and the first current control valve device 18 and between'the transistor switch 12 and thesecond current control valve device The digital programmer 22 is connected to the bases of the switching transistors Q3 and Q4 and selectively provides gating signals to these transistors. The digital programmer 22 also drives the control voltage generator 24 which, in turn, selectively produces steady-state control voltages at the bases of the first and second current control transistors Q and Q6.

Diodes 50 and 52 prevent excess reverse voltages from occurring between the bases and emitters of the current control transistors Q5 and Q6.

In operation, the electrodes 46 and 48 are connected to living tissue, such as nerves or other organs, either directly or indirectly. When it is desired to transmit biphasic pulses to the living tissue, the digital programmer 22 gates the switching transistor Q3 on and the switching transistor Q4 off for a time period of T1 and then gates the switching transistor Q4 on and switching transistor Q3 off for an identical time period T2.

During time period Tl, when the switching transistor Q3 is on, a current flow is established through the control resistors 36 and 38 to lower the potential appearing at the base of the switching transistor Q2. This places the switching transistor Q2 in an on mode of operation. Thus, a circuit is established between the positive voltage terminal 26 and the first electrode 46 through the switching transistor Q2. A circuit is also completed between the second electrode 48 and the negative voltage terminal 28 via the current control transistor Q5, the resistor 42, and diode 50, and the switching transistor Q3. Thus, a circuit is completed from the positive voltage terminal 26 to the negative voltage terminal 28 via living tissue connected to the electrodes 46 and 48. It should be noted that during time period T, both of the switching transistors Q4 and Q1 are locked in off modes.

During the time period T2 the switching transistor Q3 is turned off so that the voltage appearing at the base of the switching transistor Q2 rises to the voltage of the positive voltage terminal 26, which, in turn, turns off the switching transistor Q2. Thus, the electrode 46 is no longer connected to the high voltage terminal 26. However, the switching transistor Q4 is turned on by the digital programmer 22 so that the voltage at the base of the switching transistor Q1 rises to turn on this transistor. Thus, the electrode 48 is now in communication with the positive voltage terminal 26. Also, the other electrode 46 is now in communication with the negative voltage terminal 28 via the second current control device 20, the diode 52 and the switching transistor Q4. Thus, the polarities, and current flow, of the electrodes 46 and 48 have been reversed.

Before and after the time periods T1 and T2, the digital programmer does not place either the third or fourth switching transistors Q3 and Q4 in on modes of operation so that neither of the electrodes 46 and 48 are connected to the positive and negative voltage terminals 26 and 28. The output signal appearing at electrodes 46 and 48 before, after, and during the time periods T1 and T2 can be graphically represented as shown in FIG. 2.

In the preferred embodiment, the control voltage generator 24 provides steady-state control voltages ranging from 1.4 to 5 volts. It should be understood that the magnitude of a selected control voltage determines the magnitudes of current signals applied by the electrodes 46 and 48 to living tissue.

It should be further appreciated that the duration of the pulses can be accurately controlled by the digital programmer 22.

In addition, during periods of no pulses, since all four transistor switches are open, the electrodes 46 and 48 can be used for recording purposes.

While the invention has been particularly shown and described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention. For example, various voltage magnitudes at voltage terminals 26 and 28 could be employed and it is not necessary that one of the supply voltages be either negative or positive. With regard to voltage magni tude, the high voltage source limit is determined by the perimeters of the transistors chosen and/or by the maximum current which has to be driven through the highest expected load impedance. Further, the transistors could be replaced by other types of electrical valves.

The embodiment of the invention in which an exclusive property or privilege are claimed are defined as follows:

1. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising:

first and second voltage terminals having voltages of different magnitudes;

first and second conducting paths connected in parallel between said first and second voltage terminals, each of said first and second conducting paths including first and second switches connected in series, with said first switch being connected electrically closer to said first voltage terminal than said second switch and the intersections of said first and second switches in each of said paths defining output electrodes across which pulse-generator output bi-phasic pulses are produced;

interconnecting means for connecting said first switch of said first conducting path with said second switch of said second conducting path and said first switch of said second conducting path with said second switch of said first conducting path to respectively close and open said second switches in response to said first switches of opposite paths being opened and closed; and,

a driving means for alternately driving one of said first switches open and the other closed for a first predetermined time period, and vice versa for a second predetermined time period.

2. A bi-phasic pulse generator as in claim 1 wherein is further included current-control, valve means connected in each of said paths between said first voltage terminal and said output electrodes to thereby control the flow of current through said electrodes.

3. A bi-phasic pulse generator as in claim 2, wherein said switches and control means comprise transistors.

4. A bi-phasic pulse generator as claimed in claim 1, wherein said driving means comprises a programming circuit means for alternately driving said first switches in a programmed sequence.

5. A bi-phasic pulse generator as claimed in claim 1, wherein said output electrodes include means for electrically attaching said electrodes to living tissue.

6. A bi-phasic pulse generator for producing pulses to stimulate living tissuecomprising:

first and second voltage terminals having different voltage potentials thereon;

of said electrodes including electronic valve means for selectively controlling the magnitude of current flow between said first voltage terminal and both of said first and second electrodes; and a control means attached to said electronic valve means for selectively adjusting the flow of current through said valve means. 7. A bi-phasic pulse generator as claimed in claim 6 wherein said electronic valve means comprise transistors.

Claims (7)

1. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising: first and second voltage terminals having voltages of different magnitudes; first and second conducting paths connected in parallel between said first and second voltage terminals, each of said first and second conducting paths including first and second switches connected in series, with said first switch being connected electrically closer to said first voltage terminal than said second switch and the intersections of said first and second switches in each of said paths defining output electrodes across which pulse-generator output bi-phasic pulses are produced; interconnecting means for connecting said first switch of said first conducting path with said second switch of said second conducting path and said first switch of said second conducting path with said second switch of said first conducting path to respectively close and open said second switches in response to said first switches of opposite paths being opened and closed; and, a driving means for alternately driving one of said first switches open and the other closed for a first predetermined time period, and vice versa for a second predetermined time period.
2. A bi-phasic pulse generator as in claim 1 wherein is further included current-control, valve means connected in each of said paths between said first voltage terminal and said output electrodes to thereby control the flow of current through said electrodes.
3. A bi-phasic pulse generator as in claim 2, wherein said switches and control means comprise transistors.
4. A bi-phasic pulse generator as claimed in claim 1, wherein said driving means comprises a programming circuit means for alternately driving said first switches in a programmed sequence.
5. A bi-phasic pulse generator as claimed in claim 1, wherein said output electrodes include means for electrically attaching said electrodes to living tissue.
6. A bi-phasic pulse generator for producing pulses to stimulate living tissue comprising: first and second voltage terminals having different voltage potentials thereon; first and second output electrodes adapted to be attached to living tissue; a control circuit means connected between each of said first and second voltage terminals and to each of said output electrodes for alternately connecting said first voltage terminal to said first electrode and said second voltage terminal to said second electrode and said first voltage terminal to said second electrode and said second voltage terminal to said first electrode, said control circuit means connected between said first voltage terminal and each of said electrodes including electronic valve means for selectively controlling the magnitude of current flow between said first voltage terminal and both of said first and second electrodes; and a control means attached to said electronic valve means for selectively adjusting the flow of current through said valve means.
7. A bi-phasic pulse gEnerator as claimed in claim 6 wherein said electronic valve means comprise transistors.
US3924641A 1974-08-19 1974-08-19 Bi-phasic current stimulation system Expired - Lifetime US3924641A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US3924641A US3924641A (en) 1974-08-19 1974-08-19 Bi-phasic current stimulation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3924641A US3924641A (en) 1974-08-19 1974-08-19 Bi-phasic current stimulation system

Publications (1)

Publication Number Publication Date
US3924641A true US3924641A (en) 1975-12-09

Family

ID=23982312

Family Applications (1)

Application Number Title Priority Date Filing Date
US3924641A Expired - Lifetime US3924641A (en) 1974-08-19 1974-08-19 Bi-phasic current stimulation system

Country Status (1)

Country Link
US (1) US3924641A (en)

Cited By (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170999A (en) * 1977-08-19 1979-10-16 Biotronik Mess- Und Therapiegerate Gmbh & Co. Demand pacer having reduced recovery time
US4233965A (en) * 1978-01-16 1980-11-18 Cas Products, Inc. Method and apparatus for the therapeutic treatment of living tissue
US4327322A (en) * 1980-10-06 1982-04-27 Spatial Dynamics, Ltd. Bidirectional current supply circuit
EP0052247A2 (en) * 1980-11-13 1982-05-26 Torben Ejsing Dr. Jorgensen Arrangement for the electrical stimulation of bones in the region of fracture
US4343312A (en) * 1979-04-16 1982-08-10 Vitafin N.V. Pacemaker output circuit
US4373531A (en) * 1979-04-16 1983-02-15 Vitafin N.V. Apparatus for physiological stimulation and detection of evoked response
US4402322A (en) * 1981-03-25 1983-09-06 Medtronic, Inc. Pacer output circuit
US4446870A (en) * 1978-03-16 1984-05-08 Wing Thomas W Electrical treatment method
EP0154976A1 (en) * 1984-03-12 1985-09-18 BIO-RESEARCH ASSOCIATES, Inc. Electrical muscle stimulator
US4543956A (en) * 1984-05-24 1985-10-01 Cordis Corporation Biphasic cardiac pacer
US4561426A (en) * 1984-02-29 1985-12-31 Stewart David J Magnetic biological device
FR2586932A1 (en) * 1985-09-12 1987-03-13 Bertin & Cie Device for electrical stimulation of biological tissues
FR2587624A1 (en) * 1985-09-26 1987-03-27 Genin Jacques Method and circuits for controlling implanted electrodes for neurophysiological stimulation
US4726379A (en) * 1985-11-14 1988-02-23 Cardiac Control Systems, Inc. Cardiac pacer with switching circuit for isolation
US4800883A (en) * 1986-04-02 1989-01-31 Intermedics, Inc. Apparatus for generating multiphasic defibrillation pulse waveform
US4821723A (en) * 1987-02-27 1989-04-18 Intermedics Inc. Biphasic waveforms for defibrillation
US4846181A (en) * 1987-10-02 1989-07-11 Staodynamics, Inc. Soft tissue wound healing therapy utilizing pulsed electrical stimulation
US4926879A (en) * 1988-06-13 1990-05-22 Sevrain-Tech, Inc. Electro-tactile stimulator
US4958632A (en) * 1978-07-20 1990-09-25 Medtronic, Inc. Adaptable, digital computer controlled cardiac pacemaker
US5036850A (en) * 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
US5069211A (en) * 1989-08-25 1991-12-03 Staodyn, Inc. Microprocessor controlled electronic stimulating device having biphasic pulse output
US5135478A (en) * 1989-05-10 1992-08-04 Drug Delivery Systems Inc. Multi-signal electrical transdermal drug applicator
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5328452A (en) * 1989-05-10 1994-07-12 Drug Delivery Systems Inc. Multi-signal electrical transdermal drug application
US5330512A (en) * 1992-12-28 1994-07-19 Cardiac Pacemakers, Inc. Electrode charge-neutral sensing of evoked ECG
US5385575A (en) * 1992-03-24 1995-01-31 Angeion Corporation Implantable cardioverter defibrillator having variable output capacitance
US5411528A (en) * 1992-11-19 1995-05-02 Pacesetter, Inc. Electrically programmable polarity connector for an implantable body tissue stimulator
US5425748A (en) * 1993-08-05 1995-06-20 Ventritex, Inc. Method and apparatus for cardiac defibrillation
US5447518A (en) * 1993-08-31 1995-09-05 Ventritex, Inc. Method and apparatus for phase related cardiac defibrillation
US5456690A (en) * 1993-05-20 1995-10-10 Ventritex, Inc. System and method for fractal pulse defibrillation
US5507781A (en) * 1991-05-23 1996-04-16 Angeion Corporation Implantable defibrillator system with capacitor switching circuitry
US5833712A (en) * 1991-05-23 1998-11-10 Angeion Corporation Implantable defibrillator system for generating a biphasic waveform
US5871506A (en) * 1996-08-19 1999-02-16 Mower; Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing
WO1999044682A1 (en) * 1998-03-05 1999-09-10 Mower Morton M System and method for multiple site biphasic stimulation to revert ventricular arrhythmias
US6136019A (en) * 1996-08-19 2000-10-24 Mower Family Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6141587A (en) * 1996-08-19 2000-10-31 Mower Family Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US6141586A (en) * 1996-08-19 2000-10-31 Mower Family Chf Treatment Irrevocable Trust Method and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates
US6178351B1 (en) 1996-08-19 2001-01-23 The Mower Family Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US6295470B1 (en) 1996-08-19 2001-09-25 The Mower Family Chf Treatment Irrevocable Trust Antitachycardial pacing
US6332096B1 (en) 2000-02-16 2001-12-18 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US6337995B1 (en) 1996-08-19 2002-01-08 Mower Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention for atrial fibrillation
US6341235B1 (en) 1996-08-19 2002-01-22 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6343232B1 (en) 1966-08-19 2002-01-29 Mower Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US6411845B1 (en) 1999-03-04 2002-06-25 Mower Chf Treatment Irrevocable Trust System for multiple site biphasic stimulation to revert ventricular arrhythmias
US6411847B1 (en) 1996-08-19 2002-06-25 Morton M. Mower Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate
US6458157B1 (en) * 1997-08-04 2002-10-01 Suaning Gregg Joergen Retinal stimulator
US20040153127A1 (en) * 2003-01-15 2004-08-05 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Treatments for snoring using injectable neuromuscular stimulators
US20040167589A1 (en) * 2003-02-22 2004-08-26 Chester Heath Viral-inhibiting apparatus and methods
US7020526B1 (en) 2002-05-16 2006-03-28 Ruan Jin Zhao Electronic gastro-intestinal stimulation device
US20060129208A1 (en) * 2004-12-13 2006-06-15 Link Yu Full-range electrotherapy unit with digital force modulator
US7203537B2 (en) 1996-08-19 2007-04-10 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US20070203528A1 (en) * 2006-02-28 2007-08-30 Vernon Scott D Supply circuit for implantable medical devices
US7440800B2 (en) 1996-08-19 2008-10-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US7840264B1 (en) 1996-08-19 2010-11-23 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US7908003B1 (en) 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US8260416B2 (en) 1996-01-08 2012-09-04 Impulse Dynamics, N.V. Electrical muscle controller
US8326416B2 (en) 2003-03-10 2012-12-04 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8346363B2 (en) * 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US8447399B2 (en) 1996-08-19 2013-05-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3523539A (en) * 1968-02-26 1970-08-11 Hewlett Packard Co Demand cardiac pacemaker and method
US3563247A (en) * 1968-03-14 1971-02-16 Gen Electric Bidirectional heart stimulator
US3589370A (en) * 1967-06-09 1971-06-29 Medical Biolog Instrumentation Electronic muscle stimulator
US3727616A (en) * 1971-06-15 1973-04-17 Gen Dynamics Corp Electronic system for the stimulation of biological systems
US3835865A (en) * 1970-07-10 1974-09-17 Gen Electric Body organ stimulator

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3589370A (en) * 1967-06-09 1971-06-29 Medical Biolog Instrumentation Electronic muscle stimulator
US3523539A (en) * 1968-02-26 1970-08-11 Hewlett Packard Co Demand cardiac pacemaker and method
US3563247A (en) * 1968-03-14 1971-02-16 Gen Electric Bidirectional heart stimulator
US3835865A (en) * 1970-07-10 1974-09-17 Gen Electric Body organ stimulator
US3727616A (en) * 1971-06-15 1973-04-17 Gen Dynamics Corp Electronic system for the stimulation of biological systems

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6343232B1 (en) 1966-08-19 2002-01-29 Mower Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US4170999A (en) * 1977-08-19 1979-10-16 Biotronik Mess- Und Therapiegerate Gmbh & Co. Demand pacer having reduced recovery time
US4233965A (en) * 1978-01-16 1980-11-18 Cas Products, Inc. Method and apparatus for the therapeutic treatment of living tissue
US4446870A (en) * 1978-03-16 1984-05-08 Wing Thomas W Electrical treatment method
US4958632A (en) * 1978-07-20 1990-09-25 Medtronic, Inc. Adaptable, digital computer controlled cardiac pacemaker
US5318593A (en) * 1978-07-20 1994-06-07 Medtronic, Inc. Multi-mode adaptable implantable pacemaker
US4373531A (en) * 1979-04-16 1983-02-15 Vitafin N.V. Apparatus for physiological stimulation and detection of evoked response
US4343312A (en) * 1979-04-16 1982-08-10 Vitafin N.V. Pacemaker output circuit
US4327322A (en) * 1980-10-06 1982-04-27 Spatial Dynamics, Ltd. Bidirectional current supply circuit
EP0052247A3 (en) * 1980-11-13 1982-09-15 Torben Ejsing Dr. Jorgensen Arrangement for the electrical stimulation of bones
EP0052247A2 (en) * 1980-11-13 1982-05-26 Torben Ejsing Dr. Jorgensen Arrangement for the electrical stimulation of bones in the region of fracture
US4402322A (en) * 1981-03-25 1983-09-06 Medtronic, Inc. Pacer output circuit
US4561426A (en) * 1984-02-29 1985-12-31 Stewart David J Magnetic biological device
EP0154976A1 (en) * 1984-03-12 1985-09-18 BIO-RESEARCH ASSOCIATES, Inc. Electrical muscle stimulator
US4543956A (en) * 1984-05-24 1985-10-01 Cordis Corporation Biphasic cardiac pacer
FR2586932A1 (en) * 1985-09-12 1987-03-13 Bertin & Cie Device for electrical stimulation of biological tissues
FR2587624A1 (en) * 1985-09-26 1987-03-27 Genin Jacques Method and circuits for controlling implanted electrodes for neurophysiological stimulation
US4726379A (en) * 1985-11-14 1988-02-23 Cardiac Control Systems, Inc. Cardiac pacer with switching circuit for isolation
US4800883A (en) * 1986-04-02 1989-01-31 Intermedics, Inc. Apparatus for generating multiphasic defibrillation pulse waveform
US4821723A (en) * 1987-02-27 1989-04-18 Intermedics Inc. Biphasic waveforms for defibrillation
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US4846181A (en) * 1987-10-02 1989-07-11 Staodynamics, Inc. Soft tissue wound healing therapy utilizing pulsed electrical stimulation
US4926879A (en) * 1988-06-13 1990-05-22 Sevrain-Tech, Inc. Electro-tactile stimulator
US5135478A (en) * 1989-05-10 1992-08-04 Drug Delivery Systems Inc. Multi-signal electrical transdermal drug applicator
US5328452A (en) * 1989-05-10 1994-07-12 Drug Delivery Systems Inc. Multi-signal electrical transdermal drug application
US5069211A (en) * 1989-08-25 1991-12-03 Staodyn, Inc. Microprocessor controlled electronic stimulating device having biphasic pulse output
US5036850A (en) * 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
US5507781A (en) * 1991-05-23 1996-04-16 Angeion Corporation Implantable defibrillator system with capacitor switching circuitry
US5833712A (en) * 1991-05-23 1998-11-10 Angeion Corporation Implantable defibrillator system for generating a biphasic waveform
US5385575A (en) * 1992-03-24 1995-01-31 Angeion Corporation Implantable cardioverter defibrillator having variable output capacitance
US5411528A (en) * 1992-11-19 1995-05-02 Pacesetter, Inc. Electrically programmable polarity connector for an implantable body tissue stimulator
US5330512A (en) * 1992-12-28 1994-07-19 Cardiac Pacemakers, Inc. Electrode charge-neutral sensing of evoked ECG
US5456690A (en) * 1993-05-20 1995-10-10 Ventritex, Inc. System and method for fractal pulse defibrillation
US5425748A (en) * 1993-08-05 1995-06-20 Ventritex, Inc. Method and apparatus for cardiac defibrillation
US5447518A (en) * 1993-08-31 1995-09-05 Ventritex, Inc. Method and apparatus for phase related cardiac defibrillation
US8260416B2 (en) 1996-01-08 2012-09-04 Impulse Dynamics, N.V. Electrical muscle controller
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8301247B2 (en) 1996-01-08 2012-10-30 Impulse Dynamics, N.V. Electrical muscle controller
US8311629B2 (en) 1996-01-08 2012-11-13 Impulse Dynamics, N.V. Electrical muscle controller
US8447399B2 (en) 1996-08-19 2013-05-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US6295470B1 (en) 1996-08-19 2001-09-25 The Mower Family Chf Treatment Irrevocable Trust Antitachycardial pacing
US6178351B1 (en) 1996-08-19 2001-01-23 The Mower Family Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US6141586A (en) * 1996-08-19 2000-10-31 Mower Family Chf Treatment Irrevocable Trust Method and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates
US6341235B1 (en) 1996-08-19 2002-01-22 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US7203537B2 (en) 1996-08-19 2007-04-10 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US6141587A (en) * 1996-08-19 2000-10-31 Mower Family Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US6411847B1 (en) 1996-08-19 2002-06-25 Morton M. Mower Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate
US20020099413A1 (en) * 1996-08-19 2002-07-25 Mower Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6136019A (en) * 1996-08-19 2000-10-24 Mower Family Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US8290585B2 (en) 1996-08-19 2012-10-16 Mr3 Medical, Llc Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US5871506A (en) * 1996-08-19 1999-02-16 Mower; Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US7840264B1 (en) 1996-08-19 2010-11-23 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US6895274B2 (en) 1996-08-19 2005-05-17 The Mower Family Chf Treatment Irrevocable Trust Antitachycardial pacing
US7440800B2 (en) 1996-08-19 2008-10-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US6337995B1 (en) 1996-08-19 2002-01-08 Mower Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention for atrial fibrillation
US7908003B1 (en) 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US6458157B1 (en) * 1997-08-04 2002-10-01 Suaning Gregg Joergen Retinal stimulator
EP1064048B1 (en) * 1998-01-16 2004-10-20 Morton M. Mower Augmentation of electrical conduction and contractibility by biphasic cardiac pacing administered via the cardiac blood pool
WO1999044682A1 (en) * 1998-03-05 1999-09-10 Mower Morton M System and method for multiple site biphasic stimulation to revert ventricular arrhythmias
US6067470A (en) * 1998-03-05 2000-05-23 Mower Family Chf Treatment Irrevocable Trust System and method for multiple site biphasic stimulation to revert ventricular arrhythmias
US6411845B1 (en) 1999-03-04 2002-06-25 Mower Chf Treatment Irrevocable Trust System for multiple site biphasic stimulation to revert ventricular arrhythmias
US8346363B2 (en) * 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US6332096B1 (en) 2000-02-16 2001-12-18 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US7020526B1 (en) 2002-05-16 2006-03-28 Ruan Jin Zhao Electronic gastro-intestinal stimulation device
US7277749B2 (en) 2003-01-15 2007-10-02 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Treatments for snoring using injectable neuromuscular stimulators
US20040153127A1 (en) * 2003-01-15 2004-08-05 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Treatments for snoring using injectable neuromuscular stimulators
US20040167589A1 (en) * 2003-02-22 2004-08-26 Chester Heath Viral-inhibiting apparatus and methods
US7228184B2 (en) * 2003-02-22 2007-06-05 Chester Heath Viral-inhibiting method
US20070073372A1 (en) * 2003-02-22 2007-03-29 Chester Heath Viral-inhibiting apparatus and methods
US8326416B2 (en) 2003-03-10 2012-12-04 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US20060129208A1 (en) * 2004-12-13 2006-06-15 Link Yu Full-range electrotherapy unit with digital force modulator
US7209782B2 (en) * 2004-12-13 2007-04-24 Link Yu Full-range electrotherapy unit with digital force modutator
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US20070203528A1 (en) * 2006-02-28 2007-08-30 Vernon Scott D Supply circuit for implantable medical devices
US7852052B2 (en) 2006-02-28 2010-12-14 Medtronic, Inc. Supply circuit for implantable medical devices
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy

Similar Documents

Publication Publication Date Title
US3127895A (en) Therapeutic pulse generation and control circuit
Ron et al. Eye movements evoked by cerebellar stimulation in the alert monkey
US3403684A (en) Electrical stimulator
US4399818A (en) Direct-coupled output stage for rapid-signal biological stimulator
Lashley Basic neural mechanisms in behavior.
US4231027A (en) Battery monitoring means for an implantable living tissue stimulator
Segev et al. Computational study of an excitable dendritic spine
US5601617A (en) Multichannel cochlear prosthesis with flexible control of stimulus waveforms
US5217009A (en) Compact biomedical pulsed signal generator for bone tissue stimulation
Eckmiller Learning retina implants with epiretinal contacts
US4237899A (en) Electronic tissue stimulator with output signal controls
US3742947A (en) Optically isolated electro-medical device
US4909255A (en) Apparatus for electric stimulation therapy equipment
US4903700A (en) Pacing pulse compensation
US5324317A (en) Interferential stimulator for applying low frequency alternating current to the body
US5925070A (en) Techniques for adjusting the locus of excitation of electrically excitable tissue
US4990845A (en) Floating current source
US7539538B2 (en) Low power loss current digital-to-analog converter used in an implantable pulse generator
US4821724A (en) Pacing pulse compensation
US4989605A (en) Transcutaneous electrical nerve stimulation (TENS) device
US20030088282A1 (en) Defibrillation pacing circuitry
US6609031B1 (en) Multiprogrammable tissue stimulator and method
US3941136A (en) Method for artificially inducing urination, defecation, or sexual excitation
US6076018A (en) Method and apparatus for low power regulated output in battery powered electrotherapy devices
US4622973A (en) Programmable functional electrical stimulation system

Legal Events

Date Code Title Description
AS Assignment

Owner name: VENTRITEX, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AXOTRONICS, INC., A CORP. OF CT.;REEL/FRAME:005289/0451

Effective date: 19900420